Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Sandy_Macrae
|
| gptkbp:developedBy |
therapies for genetic diseases
|
| gptkbp:focusesOn |
genome editing
gene therapy |
| gptkbp:foundedYear |
1995
|
| gptkbp:fullName |
gptkb:Sangamo_Therapeutics,_Inc.
|
| gptkbp:headquartersLocation |
gptkb:Brisbane,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
SGTX
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:platform |
zinc finger nucleases
|
| gptkbp:stockSymbol |
gptkb:SGTX
|
| gptkbp:tradedOn |
gptkb:NASDAQ:SGTX
|
| gptkbp:website |
https://www.sangamo.com/
|
| gptkbp:bfsParent |
gptkb:Sigilon_Therapeutics
|
| gptkbp:bfsLayer |
4
|